gammaCore™ (nVNS) is the first FDA-cleared non-invasive, handheld device to treat and prevent migraine and cluster headache. gammaCore is self-administered by patients without the potential side effects associated with commonly prescribed drugs. When placed on a patient’s neck over the vagus nerve, gammaCore stimulates the nerve’s afferent fibers. FDA label expansion now includes adolescent migraine, hemicrania continua, and paroxysmal hemicrania. You can provide gammaCore as physician dispense with NEW gConcierge. Our patient training and support will maximize treatment outcomes. Stop by the Exhibit #411 to learn more. Please see ISI at gammaCore.com.